Patient-Friendly Explanation

Diethylpropion is a prescription weight loss medication that works by reducing appetite. It belongs to a class of medicines called sympathomimetic amines that affect the brain’s hunger signals. It is approved for short-term use alongside diet and exercise changes to help jump-start weight loss in people who are medically obese or overweight with health complications.

Clinical Definition

Diethylpropion (also known as amfepramone) is a Schedule IV-controlled sympathomimetic amine approved by the FDA for short-term (up to 12 weeks) treatment of obesity. It acts primarily as a norepinephrine and dopamine reuptake inhibitor, enhancing central catecholamine signalling to suppress appetite. Clinical trials demonstrate an average additional weight loss of 3 to 5 kilogrammes over placebo when combined with lifestyle intervention. Common side effects include insomnia, dry mouth, and elevated blood pressure.

Why It Matters

While newer GLP-1 receptor agonists dominate the current obesity pharmacotherapy landscape, older agents like diethylpropion remain relevant for selected patients — particularly those who cannot tolerate or afford newer treatments. NuLifeCare Singapore evaluates each patient individually to determine the most appropriate, cost-effective weight loss medication as part of a comprehensive, medically supervised programme.